About Moolec Science S.A.
https://moolecscience.comMoolec Science SA, a science-based ingredient company, focuses on producing animal proteins in plants through Molecular Farming, a disruptive technology in the alternative protein landscape. The company's product portfolio and pipeline leverage the agronomic efficiency of used target crops, such as soybeans and peas. It operates in the United States, Europe, and South America.
CEO
Alejandro Antalich
Compensation Summary
(Year )
Price Target
About Moolec Science S.A.
https://moolecscience.comMoolec Science SA, a science-based ingredient company, focuses on producing animal proteins in plants through Molecular Farming, a disruptive technology in the alternative protein landscape. The company's product portfolio and pipeline leverage the agronomic efficiency of used target crops, such as soybeans and peas. It operates in the United States, Europe, and South America.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q2-2024 | $2.64M ▲ | $1.39M ▼ | $-2.43M ▼ | -91.84% ▲ | $-0.9 ▼ | $-1.15M ▼ |
| Q1-2024 | $1.56M ▲ | $2.12M ▼ | $-1.92M ▲ | -123.02% ▲ | $-0.75 ▲ | $-1.07M ▲ |
| Q4-2023 | $1.52M ▼ | $2.87M ▲ | $-2.54M ▼ | -166.47% ▼ | $-1.05 ▼ | $-2.36M ▼ |
| Q3-2023 | $2.11M ▲ | $2.13M ▲ | $-1.4M ▲ | -66.46% ▲ | $-0.6 ▲ | $-627.06K ▲ |
| Q2-2023 | $252.11K | $1.97M | $-1.78M | -707.42% | $-0.75 | $-1.73M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q2-2024 | $1.93M ▼ | $31.38M ▼ | $28.58M ▲ | $2.8M ▼ |
| Q1-2024 | $3.61M ▼ | $32.56M ▼ | $26.87M ▼ | $5.69M ▼ |
| Q4-2023 | $5.39M ▲ | $34.79M ▲ | $27.97M ▲ | $6.82M ▲ |
| Q3-2023 | $4.25M ▲ | $25.95M ▲ | $19.31M ▲ | $6.64M ▼ |
| Q2-2023 | $1.83M | $21.32M | $14.64M | $6.68M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q2-2024 | $-2.43M ▼ | $-890.48K ▲ | $-298.86K ▼ | $-529.9K ▲ | $-1.68M ▲ | $-1.19M ▼ |
| Q1-2024 | $-1.92M ▲ | $-1.13M ▼ | $-59.74K ▼ | $-542.42K ▼ | $-1.78M ▼ | $-1.19M ▼ |
| Q4-2023 | $-2.54M ▼ | $-1.04M ▲ | $-24.05K ▼ | $2.2M ▼ | $1.14M ▼ | $-1.07M ▲ |
| Q3-2023 | $-1.4M ▲ | $-2.64M ▲ | $112.48K ▲ | $4.82M ▼ | $2.55M ▲ | $-2.67M ▲ |
| Q2-2023 | $-1.78M | $-4.06M | $-128.13K | $4.97M | $847.89K | $-4.05M |
CEO
Alejandro Antalich